Moberg Pharma AB (Formerly known as Moberg Derma) Year-End Report For 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Moberg (STO:MOB):

FOURTH QUARTER (OCT-DEC 2013)

•Revenue MSEK 36.8 (30.2)

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC